These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33958861)

  • 21. Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.
    Zicha S; Bateman RJ; Shaw LM; Zetterberg H; Bannon AW; Horton WA; Baratta M; Kolb HC; Dobler I; Mordashova Y; Saad ZS; Raunig DL; Spanakis EM; Li Y; Schindler SE; Ferber K; Rubel CE; Martone RL; Weber CJ; Edelmayer RM; Meyers EA; Bollinger JG; Rosenbaugh EG; Potter WZ; ;
    Alzheimers Dement; 2023 Mar; 19(3):956-966. PubMed ID: 35820077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity.
    Pyun JM; Park YH; Youn YC; Kang MJ; Shim KH; Jang JW; You J; Nho K; Kim S;
    Transl Psychiatry; 2024 Feb; 14(1):88. PubMed ID: 38341444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.
    Toledo JB; Habes M; Sotiras A; Bjerke M; Fan Y; Weiner MW; Shaw LM; Davatzikos C; Trojanowski JQ;
    J Alzheimers Dis; 2019; 69(3):783-793. PubMed ID: 31127775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.
    Rippon B; Palta P; Tahmi M; Sherwood G; Soto L; Cespedes S; Mesen Y; He H; Laing K; Moreno H; Teresi J; Razlighi Q; Brickman AM; Zetterberg H; Luchsinger JA
    J Alzheimers Dis; 2022; 87(3):1229-1238. PubMed ID: 35466933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
    Keshavan A; Pannee J; Karikari TK; Rodriguez JL; Ashton NJ; Nicholas JM; Cash DM; Coath W; Lane CA; Parker TD; Lu K; Buchanan SM; Keuss SE; James SN; Murray-Smith H; Wong A; Barnes A; Dickson JC; Heslegrave A; Portelius E; Richards M; Fox NC; Zetterberg H; Blennow K; Schott JM
    Brain; 2021 Mar; 144(2):434-449. PubMed ID: 33479777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High performance plasma amyloid-β biomarkers for Alzheimer's disease.
    Nakamura A; Kaneko N; Villemagne VL; Kato T; Doecke J; Doré V; Fowler C; Li QX; Martins R; Rowe C; Tomita T; Matsuzaki K; Ishii K; Ishii K; Arahata Y; Iwamoto S; Ito K; Tanaka K; Masters CL; Yanagisawa K
    Nature; 2018 Feb; 554(7691):249-254. PubMed ID: 29420472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms.
    Palmqvist S; Insel PS; Zetterberg H; Blennow K; Brix B; Stomrud E; ; ; Mattsson N; Hansson O
    Alzheimers Dement; 2019 Feb; 15(2):194-204. PubMed ID: 30365928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes.
    Carandini T; Arighi A; Sacchi L; Fumagalli GG; Pietroboni AM; Ghezzi L; Colombi A; Scarioni M; Fenoglio C; De Riz MA; Marotta G; Scarpini E; Galimberti D
    Alzheimers Res Ther; 2019 Oct; 11(1):84. PubMed ID: 31615545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
    Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
    J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
    Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O
    JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of plasma amyloid-β oligomerization with theta/beta ratio in older adults.
    Bae H; Kang MJ; Ha SW; Jeong DE; Lee K; Lim S; Min JY; Min KB
    Front Aging Neurosci; 2023; 15():1291881. PubMed ID: 38106526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
    Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN
    J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment.
    Hu Y; Kirmess KM; Meyer MR; Rabinovici GD; Gatsonis C; Siegel BA; Whitmer RA; Apgar C; Hanna L; Kanekiyo M; Kaplow J; Koyama A; Verbel D; Holubasch MS; Knapik SS; Connor J; Contois JH; Jackson EN; Harpstrite SE; Bateman RJ; Holtzman DM; Verghese PB; Fogelman I; Braunstein JB; Yarasheski KE; West T
    JAMA Netw Open; 2022 Apr; 5(4):e228392. PubMed ID: 35446396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
    Jansen WJ; Ossenkoppele R; Tijms BM; Fagan AM; Hansson O; Klunk WE; van der Flier WM; Villemagne VL; Frisoni GB; Fleisher AS; Lleó A; Mintun MA; Wallin A; Engelborghs S; Na DL; Chételat G; Molinuevo JL; Landau SM; Mattsson N; Kornhuber J; Sabri O; Rowe CC; Parnetti L; Popp J; Fladby T; Jagust WJ; Aalten P; Lee DY; Vandenberghe R; Resende de Oliveira C; Kapaki E; Froelich L; Ivanoiu A; Gabryelewicz T; Verbeek MM; Sanchez-Juan P; Hildebrandt H; Camus V; Zboch M; Brooks DJ; Drzezga A; Rinne JO; Newberg A; de Mendonça A; Sarazin M; Rabinovici GD; Madsen K; Kramberger MG; Nordberg A; Mok V; Mroczko B; Wolk DA; Meyer PT; Tsolaki M; Scheltens P; Verhey FRJ; Visser PJ; ; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BNM; Blennow K; van Buchem MA; Cavedo E; Chen K; Chipi E; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gkatzima O; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Johannsen P; Klimkowicz-Mrowiec A; Köhler S; Koglin N; van Laere K; de Leon M; Lisetti V; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Nordlund A; Novak GP; Paraskevas GP; Perera G; Peters O; Ramakers IHGB; Rami L; Rodríguez-Rodríguez E; Roe CM; Rot U; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Zetterberg H
    JAMA Psychiatry; 2018 Jan; 75(1):84-95. PubMed ID: 29188296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ
    An SSA; Lee BS; Yu JS; Lim K; Kim GJ; Lee R; Kim S; Kang S; Park YH; Wang MJ; Yang YS; Youn YC; Kim S
    Alzheimers Res Ther; 2017 Oct; 9(1):86. PubMed ID: 29041968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine Learning for the Prediction of Amyloid Positivity in Amnestic Mild Cognitive Impairment.
    Kang SH; Cheon BK; Kim JS; Jang H; Kim HJ; Park KW; Noh Y; Lee JS; Ye BS; Na DL; Lee H; Seo SW
    J Alzheimers Dis; 2021; 80(1):143-157. PubMed ID: 33523003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.